​

Funding Round

Series E - Peloton Therapeutics

Series E - Peloton Therapeutics

Investment Firm

Overview

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Announced Date

Feb 20, 2019

Funding Type

Series E

Highlights

Location

United States, North America

Social

Investor Lead

RA Capital Management

RA Capital Management

RA Capital Management is a convertible_note and debt and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

11

Investor Name
Participant InvestorRA Capital Management
Participant InvestorEcoR1 Capital
Participant InvestorOrbiMed
Participant InvestorTopspin Partners
Participant InvestorThe Column Group

Round Details and Background

Peloton Therapeutics raised $150000000 on 2019-02-20 in Series E

Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Feb 20, 2019
Series E - Peloton Therapeutics
14-150.0M
Mar 14, 2017
Series D - Peloton Therapeutics
1-22.2M
Sep 15, 2016
Series D - Peloton Therapeutics
7-52.4M
Jul 27, 2011
Series A - Peloton Therapeutics
2-18.0M

Recent Activity

There is no recent news or activity for this profile.